Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.2.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Ruiyi Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States. Hauptthemen laut MEDLINE: Glaucoma, Ocular Hypertension. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Boston University School of Medicine, Department of Ophthalmology, Boston, Massachusetts, United States.
- Aerie Pharmaceuticals, Inc., Durham, North Carolina, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Ren, R., Humphrey, A. A., Kopczynski, C., & Gong, H. (2023). Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.2.7
Vancouver
Ren R, Humphrey AA, Kopczynski C, Gong H. Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.2.7
BibTeX
@article{Ren2023,
author = {Ren, Ruiyi and Humphrey, Anne A and Kopczynski, Casey and Gong, Haiyan},
title = {Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.2.7}
}
EUVIMED